Harrow reports iheezo® patient discomfort results after intravitreal injections
Harrow announces iheezo® patient-reported discomfort data following intravitreal injections, citing lower discomfort at all post-injection assessments and statistically significant differences versus comparator at every time point.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.